SCHEMBL17940134

SCHEMBL17940134

CCN(CC)c1ccc(-c2oc3cc4ccccc4cc3c(=O)c2O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.49
▸ KDM4E B2RXH2 7/20 0.49
▸ TP53 P04637 7/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.48
▸ CYP3A4 P08684 7/20 0.48
▸ MEN1 O00255 7/20 0.48
▸ KMT2A Q03164 7/20 0.48
▸ HSD17B10 Q99714 6/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ CASP1 P29466 3/20 0.48
▸ CASP7 P55210 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ ALOX15 P16050 3/20 0.48
▸ LMNA P02545 2/20 0.48
▸ RET P07949 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ KDR P35968 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ MAPK1 P28482 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17940149 0.86 ALDH1A1 (0.39) MAPTKDM4ETP53CYP3A4MEN1
SCHEMBL19833677 0.85 TP53 (0.67) MAPTKDM4ETP53RXFP1CYP3A4
SCHEMBL30888820 0.85 TP53 (0.67) MAPTKDM4ETP53RXFP1CYP3A4
SCHEMBL17944028 0.82 TP53 (0.70) MAPTKDM4ETP53RXFP1CYP3A4
SCHEMBL17940142 0.82 CYP3A4 (0.68) MAPTKDM4ETP53CYP3A4MEN1
SCHEMBL1259555 0.79 MAPT (0.51) MAPTKDM4ETP53RXFP1CYP3A4
SCHEMBL17943841 0.79 KDM4E (0.52) MAPTKDM4ETP53CYP3A4MEN1
SCHEMBL17940164 0.78 KDM4E (0.56) MAPTKDM4ETP53CYP3A4MEN1
SCHEMBL17944301 0.77 KDM4E (0.46) MAPTKDM4ETP53RXFP1CYP3A4
SCHEMBL17944015 0.75 KDM4E (0.57) MAPTKDM4ETP53CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840488-B2 Carbon monoxide releasing molecules and associated methods UTAH STATE UNIVERSITY (US) 2017-12-12 — — US disclosed
US-9840488-B2 Carbon monoxide releasing molecules and associated methods UTAH STATE UNIVERSITY (US) 2017-12-12 — — US disclosed
US-9840488-B2 Carbon monoxide releasing molecules and associated methods UTAH STATE UNIVERSITY (US) 2017-12-12 — — US disclosed
WO-2016123141-A1 CARBON MONOXIDE RELEASING MOLECULES AND ASSOCIATED METHODS BERREAU LISA M (US) 2016-08-04 — — WO disclosed
US-20160214955-A1 Carbon Monoxide Releasing Molecules and Associated Methods UTAH STATE UNIVERSITY (US) 2016-07-28 — — US disclosed
US-20160214955-A1 Carbon Monoxide Releasing Molecules and Associated Methods UTAH STATE UNIVERSITY (US) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214955-A1 Carbon Monoxide Releasing Molecules and Associated Methods MB, CORO1C, CYCS MAPT 2371/4885KDM4E 1691/4885TP53 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback